Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 21 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E4.55 EPS (ttm)0.91 Insider Own12.02% Shs Outstand12.99M Perf Week8.38%
Market Cap53.78M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float11.43M Perf Month-5.26%
Income11.95M PEG1.68 EPS next Q- Inst Own81.49% Short Float9.46% Perf Quarter-20.84%
Sales257.55M P/S0.21 EPS this Y- Inst Trans-1.44% Short Ratio7.37 Perf Half Y-17.69%
Book/sh19.25 P/B0.22 EPS next Y- ROA3.04% Short Interest1.08M Perf Year-78.90%
Cash/sh1.18 P/C3.50 EPS next 5Y2.70% ROE4.88% 52W Range3.21 - 23.52 Perf YTD-20.84%
Dividend Est.- P/FCF- EPS past 5Y-3.56% ROI3.80% 52W High-82.40% Beta0.45
Dividend TTM- Quick Ratio1.61 Sales past 5Y- Gross Margin69.74% 52W Low28.97% ATR (14)0.32
Dividend Ex-Date- Current Ratio2.16 EPS Y/Y TTM-49.41% Oper. Margin16.49% RSI (14)53.70 Volatility7.55% 9.36%
Employees- Debt/Eq0.29 Sales Y/Y TTM-5.38% Profit Margin4.64% Recom3.00 Target Price17.00
Option/ShortYes / Yes LT Debt/Eq0.25 EPS Q/Q153.33% Payout- Rel Volume0.87 Prev Close4.07
Sales Surprise9.36% EPS Surprise12.38% Sales Q/Q-12.80% Earnings- Avg Volume146.80K Price4.14
SMA2010.57% SMA50-2.02% SMA200-45.04% Trades Volume128,039 Change1.72%
Date Action Analyst Rating Change Price Target Change
Aug-10-23Downgrade Piper Sandler Neutral → Underweight $26 → $17
Aug-09-23Downgrade Piper Sandler Neutral → Underweight $26 → $17
Apr-07-21Resumed RBC Capital Mkts Outperform $52
Nov-01-18Downgrade Cantor Fitzgerald Overweight → Neutral
Oct-31-18Downgrade Piper Jaffray Overweight → Neutral
Mar-21-18Reiterated Mizuho Underperform $37 → $40
Nov-09-17Reiterated RBC Capital Mkts Outperform $81 → $75
Sep-06-17Reiterated Mizuho Underperform $40 → $37
Jul-27-17Reiterated RBC Capital Mkts Outperform $94 → $81
Jul-27-17Reiterated Mizuho Underperform $57 → $40
May-22-24 09:00AM
Apr-30-24 08:00AM
Apr-15-24 07:00AM
Apr-12-24 04:05PM
Feb-05-24 09:55AM
04:05PM Loading…
Feb-01-24 04:05PM
Jan-26-24 12:33PM
Jan-24-24 09:45AM
Jan-18-24 06:50AM
Jan-12-24 10:12AM
Jan-10-24 10:00AM
Jan-08-24 05:43PM
Jan-05-24 02:03PM
Jan-01-24 09:50AM
Dec-29-23 02:21PM
11:07AM Loading…
Dec-25-23 11:07AM
Dec-22-23 01:59PM
Dec-18-23 02:31PM
Dec-14-23 02:18PM
Dec-11-23 02:30PM
Dec-06-23 04:05PM
Dec-05-23 03:59PM
Dec-04-23 03:19PM
Dec-01-23 03:06PM
Nov-30-23 04:30PM
Nov-29-23 02:50PM
09:35AM Loading…
Nov-27-23 09:35AM
Nov-10-23 09:35AM
Nov-09-23 07:30AM
Nov-08-23 08:30AM
Nov-02-23 10:00AM
Oct-24-23 08:40AM
Oct-23-23 06:50AM
Oct-13-23 08:36AM
Oct-04-23 06:50AM
Sep-19-23 04:05PM
Sep-11-23 06:50AM
Aug-30-23 06:50AM
Aug-29-23 06:50AM
Aug-22-23 04:05PM
Aug-17-23 06:50AM
Aug-11-23 09:40AM
Aug-09-23 07:13AM
Aug-08-23 08:15AM
Aug-01-23 06:50AM
Jul-31-23 06:50AM
Jul-24-23 06:50AM
Jul-18-23 08:56AM
Jul-11-23 06:14AM
Jun-15-23 06:50AM
Jun-14-23 06:50AM
Jun-02-23 06:46PM
May-11-23 06:50AM
May-09-23 08:05AM
May-05-23 06:21AM
May-01-23 06:50AM
Apr-27-23 04:30PM
Apr-26-23 08:00PM
Apr-05-23 06:50AM
Mar-25-23 08:01AM
Mar-14-23 11:26AM
Mar-13-23 11:11PM
Mar-09-23 04:10PM
Mar-03-23 06:50AM
Jan-10-23 02:00PM
Jan-03-23 07:09AM
Dec-29-22 09:40AM
Dec-21-22 04:30PM
Dec-19-22 06:50AM
Dec-13-22 09:40AM
Dec-12-22 06:50AM
Dec-06-22 05:50AM
Dec-01-22 06:50AM
Nov-16-22 06:50AM
Nov-14-22 06:50AM
Nov-09-22 06:50AM
Nov-07-22 08:05AM
Nov-03-22 09:40AM
Nov-02-22 10:01AM
Nov-01-22 10:24AM
Oct-31-22 06:50AM
Oct-19-22 04:39PM
Oct-12-22 06:50AM
Oct-03-22 06:50AM
Sep-27-22 10:59AM
Sep-26-22 08:06AM
Sep-09-22 06:36AM
Eagle Pharmaceuticals, Inc. is a biotechnology pharmaceutical company, which focuses on developing and commercializing injectable products primarily in the metabolic critical care and oncology areas in the United States. Its products include RYANODEX, BENDEKA and BELRAPZO. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Tarriff ScottCEONov 02 '23Sale13.8710,694148,326545,447Nov 03 04:39 PM
Tarriff ScottCEONov 01 '23Sale13.8210,925150,984556,141Nov 03 04:39 PM
Graves MichaelDirectorOct 27 '23Option Exercise4.949,36046,23810,360Oct 31 05:41 PM
Tarriff ScottCEOOct 03 '23Sale14.4610,734155,174567,066Oct 04 05:07 PM
Tarriff ScottCEOOct 02 '23Sale15.239,511144,853577,800Oct 04 05:07 PM